RxDoctor Payments Data

Glenn Waldt, DO

Neuromusculoskeletal Medicine & OMM · Las Cruces, NMNPI 1437219698

Payments from drug & device makers

$256in general payments, 2019–2025

Across 5 payments — averaging $51.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Redhill Biopharma Inc.$71
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • Emergent Biosolutions Inc.$45
  • GRT US Holding, Inc.$45
  • AbbVie$36

What the payments were for

  • Food & beverage$256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few neuromusculoskeletal medicine & omm providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$471,365
Medicare patients
201
Services billed
7,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol33$327
Meloxicam73$248

Paid to pharmacies, not to this prescriber.

Other neuromusculoskeletal medicine & omm in Las Cruces

Where these figures come from

Is this you, or does something look wrong? →